158 related articles for article (PubMed ID: 28162137)
21. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson's disease.
Jones JD; Valenzuela YG; Uribe C; Bunch J; Kuhn TP
Neuropsychology; 2022 Sep; 36(6):513-519. PubMed ID: 35377683
[TBL] [Abstract][Full Text] [Related]
23. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.
Santangelo G; Vitale C; Picillo M; Moccia M; Cuoco S; Longo K; Pezzella D; di Grazia A; Erro R; Pellecchia MT; Amboni M; Trojano L; Barone P
Parkinsonism Relat Disord; 2015 Oct; 21(10):1219-26. PubMed ID: 26321021
[TBL] [Abstract][Full Text] [Related]
24. Intervening Effects of Orthostatic Blood Pressure Change on Subcortical Atrophy and Cognition in De Novo and Drug-Naïve Parkinson's Disease.
Yoo SW; Oh YS; Yoo JY; Ryu DW; Lee KS; Shin NY; Kim JS
J Parkinsons Dis; 2020; 10(1):153-160. PubMed ID: 31561388
[TBL] [Abstract][Full Text] [Related]
25. Post-stroke cognitive impairment - A cross-sectional comparison study between mild cognitive impairment of vascular and non-vascular etiology.
Divya KP; Menon RN; Varma RP; Sylaja PN; Thomas B; Kesavadas C; Sunitha J; Lekha VS; Deepak S
J Neurol Sci; 2017 Jan; 372():356-362. PubMed ID: 27836108
[TBL] [Abstract][Full Text] [Related]
26. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.
Mak E; Zhou J; Tan LC; Au WL; Sitoh YY; Kandiah N
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):576-80. PubMed ID: 24133286
[TBL] [Abstract][Full Text] [Related]
27. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
Hobson P; Meara J
Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
[TBL] [Abstract][Full Text] [Related]
28. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
Swallow DM; Lawton MA; Grosset KA; Malek N; Klein J; Baig F; Ruffmann C; Bajaj NP; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Hu MT; Grosset DG
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1183-1190. PubMed ID: 27671901
[TBL] [Abstract][Full Text] [Related]
29. Salience and Default Mode Network Coupling Predicts Cognition in Aging and Parkinson's Disease.
Putcha D; Ross RS; Cronin-Golomb A; Janes AC; Stern CE
J Int Neuropsychol Soc; 2016 Feb; 22(2):205-15. PubMed ID: 26888617
[TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
Vasconcellos LF; Pereira JS
J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
[TBL] [Abstract][Full Text] [Related]
31. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
32. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
33. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of executive function impairment in Parkinson's disease patients without dementia.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
J Int Neuropsychol Soc; 2010 Mar; 16(2):268-77. PubMed ID: 20003582
[TBL] [Abstract][Full Text] [Related]
35. Aerobic Exercise Improves Mood, Cognition, and Language Function in Parkinson's Disease: Results of a Controlled Study.
Altmann LJ; Stegemöller E; Hazamy AA; Wilson JP; Bowers D; Okun MS; Hass CJ
J Int Neuropsychol Soc; 2016 Oct; 22(9):878-889. PubMed ID: 27655232
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
[TBL] [Abstract][Full Text] [Related]
37. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
38. Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1.
Stefanova E; Žiropadja L; Stojković T; Stanković I; Tomić A; Ječmenica-Lukić M; Petrović I; Kostić V
Dement Geriatr Cogn Disord; 2015; 40(3-4):199-209. PubMed ID: 26226988
[TBL] [Abstract][Full Text] [Related]
39. Resting state functional connectivity is associated with cognitive dysfunction in non-demented people with Parkinson's disease.
Disbrow EA; Carmichael O; He J; Lanni KE; Dressler EM; Zhang L; Malhado-Chang N; Sigvardt KA
J Parkinsons Dis; 2014; 4(3):453-65. PubMed ID: 24662193
[TBL] [Abstract][Full Text] [Related]
40. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
